English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Shire

Kacie Whaley | Sep 1, 2017

Rare disease therapy company, Shire, making executive changes

Marian Johns | Aug 29, 2017

Shire, MircoHealth partner on app for hemophilia patients

Nicholas Gueguen | Aug 1, 2017

Immunodeficiency disease patients report higher quality of life with CUVITRU treatment

Erianne Leatherman | May 22, 2017

Shire outlines ADHD research at American Psychiatric Association meeting

Robert Hadley | Apr 7, 2017

FDA accelerates review for drug that treats blood-clotting disease

Gene Johnson | Mar 5, 2017

Shire honors Rare Disease Day with launch of 'Rare Count'

Keri Carbaugh | Feb 17, 2017

Shire provides latest data on Hunter's syndrome, Gaucher disease

Keri Carbaugh | Jan 8, 2017

Shire names Clark non-executive director

Trending

+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'

Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas

Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'

Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval



Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily